Molecular Diagnostics | STR Engraftment Separated Lineages

UWHC Lab Test Details
Test NameSTR Engraftment Separated Lineages
Test Code(s)HCSTRSEP
CPT Code(s)81268x2
MethodologyPCR
Clinical Information

Typically used to assess proportions of donor- and recipient-derived CD3+ and CD33+ cells post stem cell transplant or in cases of suspected graft-vs-host disease.

Days PerformedOnce a week.
In-Lab Turnaround Time10 days.
Stat In-Lab Turnaround TimeNot available stat.
Collection Requirements
SpecimenBlood
Collection Container
Collection ContainerLavender top
Collection Instructions

Extracted nucleic acid specimens may occasionally be received in cases where no primary sample is available for testing.  All nucleic acid specimens received for testing must have been extracted in a CLIA-certified laboratory or a laboratory meeting equivalent requirements as determined by the CAP and/or the CMS.

 

Specific sub-populations of white blood cells may be submitted for analysis. If separated by an outside lab, please identify the population on the label.

 

Specimens must be received by the UWHC Molecular Diagnostics Lab no later than noon on Fridays or the day before a holiday in order to be processed in a timely manner. Specimens do not remain stable for more than 24 hours.

Collection Volume8 mL
Pediatric Collection Volume2 mL
Specimen Processing Requirements
Stability
Stability Ambient

24 hours

Stability Refrigerated

Not acceptable

Stability Frozen

Not acceptable

Testing Volume2 mL
Pediatric Testing Volume2 mL
Specimen Processing

Do not refridgerate, freeze or centrifuge.

Outreach Specimen Processing

Do not refridgerate, freeze or centrifuge

Specimen Transport

Transport specimen to laboratory immediately.

Unacceptable Criteria

Whole blood specimens greater than 24 hours old when received by laboratory, refridgerated, frozen or centrifuged specimens are not acceptable.

Interpretation
Interpretive Guidelines

Sensitivity of detection of donor(s) in recipient is assessed for each combination of donor(s)/recipient.

 

 > 98% Donor DNA  Predominantly Donor
 < 2% Donor DNA  Predominantly Recipient
 2-98% Donor DNA  Donor/Recipient Chimeric
Additional Information

The specimen collected is processed by the UWHC Molecular Diagnostics Laboratory to extract CD3+ and CD33+ cell lineages. Each lineage is tested separately to quantitate and report independently the percentages of donor-derived cells. Test requires pre-transplant DNA samples on file in the laboratory for recipient and donor.

 

The performance characteristics of this test were validated by UWHC Clinical Laboratories. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test; however, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The UWHC Clinical Laboratories is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing.